» Articles » PMID: 22127311

Genomic Profiling of B-progenitor Acute Lymphoblastic Leukemia

Overview
Publisher Elsevier
Specialty Hematology
Date 2011 Dec 1
PMID 22127311
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood acute lymphoblastic leukemia (ALL) is comprised of multiple subtypes defined by recurring chromosomal alterations that are important events in leukemogenesis and are widely used in diagnosis and risk stratification, yet fail to fully explain the biology of this disease. In the last 5 years, genome-wide profiling of gene expression, structural DNA alterations and sequence variations has yielded important insights into the nature of submicroscopic genetic alterations that define novel subgroups of acute lymphoblastic leukemia and cooperate with known cytogenetic alterations in leukemogenesis. Importantly, several of these alterations are important determinants of risk of relapse and are potential targets for therapeutic intervention. Here, these advances and future directions in the genomic analysis of ALL are discussed.

Citing Articles

RanBALL: An Ensemble Random Projection Model for Identifying Subtypes of B-Cell Acute Lymphoblastic Leukemia.

Li L, Xiao H, Wu X, Tang Z, Khoury J, Wang J bioRxiv. 2024; .

PMID: 39386448 PMC: 11463541. DOI: 10.1101/2024.09.24.614777.


Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies.

Olejarz W, Sadowski K, Szulczyk D, Basak G Int J Mol Sci. 2024; 25(14).

PMID: 39062986 PMC: 11276786. DOI: 10.3390/ijms25147743.


Gene Mutations Related to Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia.

Zhang J, Zeng L, Wang Y, Pan J, Li X, Feng B Front Pediatr. 2022; 10:831229.

PMID: 35733807 PMC: 9207762. DOI: 10.3389/fped.2022.831229.


Simultaneous monitoring of disease and microbe dynamics through plasma DNA sequencing in pediatric patients with acute lymphoblastic leukemia.

Barsan V, Xia Y, Klein D, Gonzalez-Pena V, Youssef S, Inaba Y Sci Adv. 2022; 8(16):eabj1360.

PMID: 35442732 PMC: 9020671. DOI: 10.1126/sciadv.abj1360.


An updated account on molecular heterogeneity of acute leukemia.

Rahul E, Goel H, Chopra A, Ranjan A, Gupta A, Meena J Am J Blood Res. 2021; 11(1):22-43.

PMID: 33796387 PMC: 8010602.


References
1.
Mullighan C . Single nucleotide polymorphism microarray analysis of genetic alterations in cancer. Methods Mol Biol. 2011; 730:235-58. DOI: 10.1007/978-1-61779-074-4_17. View

2.
Pardanani A, Lasho T, Finke C, Oh S, Gotlib J, Tefferi A . LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations. Leukemia. 2010; 24(10):1713-8. DOI: 10.1038/leu.2010.163. View

3.
Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R . Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004; 36(10):1084-9. DOI: 10.1038/ng1425. View

4.
Harewood L, Robinson H, Harris R, Al-Obaidi M, Jalali G, Martineau M . Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia. 2003; 17(3):547-53. DOI: 10.1038/sj.leu.2402849. View

5.
Paulsson K, Cazier J, MacDougall F, Stevens J, Stasevich I, Vrcelj N . Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease. Proc Natl Acad Sci U S A. 2008; 105(18):6708-13. PMC: 2373322. DOI: 10.1073/pnas.0800408105. View